Targeting of CH25H to boost p62-dependent autophagic degradation of α-synuclein in cell and mouse models of Parkinson’s disease | Science Translational Medicine
Competitive binding of cholesterol 25-hydroxylase with p62 inhibits autophagic degradation of α-synuclein.
